19.3% Weight Loss at Week 48: Phase Ⅲ Data of Olatorepatide, Hansoh's Dual‑Biased GLP‑1/GIP Agonist, Presented at EASD
MILAN, Oct. 2, 2026 /PRNewswire/ -- From September 28 to October 2, 2026, the Annual Meeting of the European Association for the Study of Diabetes (EASD) is being held in Milan, Italy. Hansoh Pharma's self-developed dual-biased glucagon-like peptide-1/glucose-dependent insulinotropic...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Gareth Parker-Jones nombrado director fundador de Wellington College International Kenya
- TAYLOR DEVICES ANNOUNCES FIRST QUARTER RESULTS
- Ditto wurde im „KuppingerCole Analysts Leadership Compass" von KuppingerCole Analysts im Bereich Identity Verification als Leader ausgezeichnet
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →